Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    ORIC-944

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ORIC Pharma's ORIC-944 Trial Shows Best-in-Class Results
    ORIC Pharma's ORIC-944 Trial Shows Best-in-Class Results

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187843/0/en/ORIC-Pharmaceuticals-Announces-Completion-of-Dose-Exploration-Portion-of-ORIC-944-Phase-1b-Clinical-Trial-and-Continues-to-Demonstrate-Potential-Best-in-Class-Efficacy-and-Safety.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    ORIC Presents Data on ORIC-944 Showing Promise in Solid Tumors
    ORIC Presents Data on ORIC-944 Showing Promise in Solid Tumors

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174568/0/en/ORIC-Pharmaceuticals-Presented-Preclinical-Data-at-the-EORTC-NCI-AACR-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics-Supporting-Best-in-Class-Potential-of-OR.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    ORIC Pharma Presents Preclinical Data on ORIC-944 at AACR 2025
    ORIC Pharma Presents Preclinical Data on ORIC-944 at AACR 2025

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069677/0/en/ORIC-Pharmaceuticals-Presents-Preclinical-Data-to-Support-the-Potential-of-ORIC-944-as-a-Best-in-Class-PRC2-Inhibitor-for-the-Treatment-of-Prostate-Cancer-at-the-2025-American-Asso.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share